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technique provides high-resolution images of the
intestinal wall and the paraesophageal region. Gen-
erally the sensitivity of EUS in the detection of medi-
astinal lymph node involvement approximates 80%,
and there is some evidence that EUS is more accurate
than computed tomography (69% vs 51%).4 However, it
remains difficult to distinguish malignant and benign
lesions reliably. The specificity of EUS in the identifi-
cation of metastatic lymph node involvement ranges
between 50% and 70%.5 Therefore mediastinal biopsy
is still necessary to achieve a precise diagnosis of medi-
astinal lesions.6
Recently echoendoscopes with linear-array transdu-
cers have been developed that allow EUS-guided biop-
sy of extraluminal lesions.7 However, as yet mainly pre-
liminary information is available on the relevance of
this new method for the evaluation of mediastinal
tumors.7-9 The purpose of this prospective study was to
investigate the value of EUS-guided biopsy for the
diagnosis of mediastinal lesions.
T he value of computed tomography and magneticresonance imaging for imaging of mediastinal
tumors and lymph nodes has been evaluated extensive-
ly.1,2 Although mediastinal lesions can be visualized
with computed tomography and magnetic resonance
imaging, a definitive diagnosis is generally not obtained
solely on the basis of morphologic characteristics.3
In recent years endoscopic ultrasound (EUS) has been
increasingly used for staging of esophageal cancer. This
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Patients and methods
Overall, 81 patients underwent EUS with ultrasound-guid-
ed fine needle biopsy for the evaluation of mediastinal (n =
29) or abdominal tumors (n = 52). Informed consent was
obtained from all patients. Transesophageal biopsy was per-
formed in 25 patients with mediastinal lesions and 4 patients
with pulmonary tumors. The patients comprised 17 men and
12 women with a mean age of 58 years (range, 38-74 years).
Three patients with mediastinal lesions were excluded from
the analysis of the data because the diagnostic information
was not yet sufficient to establish a precise diagnosis.
For EUS the patients were placed in the left lateral decubi-
tus position. Midazolam (3-5 mg) was administered intra-
venously for conscious sedation. A 60-degree oblique view-
ing fiberoptic endoscope (Pentax FG 32UA, Pentax,
Hamburg, Germany) with a curved array transducer (7.5
MHz) was used for all examinations. The 100-degree scan
plane of the transducer is oriented along the longitudinal axis
of the endoscope, which allows real-time visualization of the
biopsy needle. EUS images were displayed on a CS9600
ultrasound unit (Ecoscan, Wiesbaden, Germany). 
A specially designed needle device (Mandel & Rupp,
Erkrath, Germany) was used for EUS-guided aspiration biop-
sy.10 The device consists of a 140-cm long stainless steel nee-
dle with a diameter of 0.8 mm, which is guided through a 5F
metal sheath. The biopsy needle can be advanced with a han-
dle. When a lesion was displayed with EUS, catheter and nee-
dle were passed through the working channel until the
catheter just reached the viewing field. Then the needle was
filled with sterile saline solution and introduced into the tar-
get. Fine needle aspiration biopsy was achieved by applying
suction with a 5-ml syringe while the needle was advanced
and withdrawn several times. Generally 4 to 6 passes were
required to obtain adequate tissue samples. The duration of
the whole procedure ranged between 10 and 20 minutes.
The biopsy specimens were placed in formaldehyde.
Conventional staining was used for histologic analysis.
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Additionally, immunohistochemistry was performed in sel-
ected cases if the results of routine staining were inconclusive. 
All patients underwent a follow-up program with examina-
tions every 3 months. Progressive disease confirmed malig-
nancy in all patients whose biopsy specimens had histologic
characteristics of malignant disease. Surgery was performed
in 4 of 6 patients with benign histologic characteristics and
confirmed the diagnosis in all cases. In the 2 remaining
patients with a history of cancer (esophageal cancer and non-
Hodgkin’s lymphoma) and benign histologic characteristics,
there is no evidence of malignancy after follow-up periods of
9 and 7 months, respectively.
Results
EUS with the 7.5-MHz curved array transducer pro-
vided high-resolution images of the gastrointestinal
tract and the adjacent structures. The longitudinal scan
plane of the transducer enabled accurate real-time visu-
alization of the needle during the biopsy procedure
(Figs 1 and 2). This technique allowed the precise biopsy
of even small mediastinal lesions with a diameter of less
than 1 cm. Diagnostic tissue samples were obtained in
23 of 26 patients (88%). All specimens were adequate
for histopathologic assessment. Additionally, immuno-
histochemistry was performed in 7 cases to achieve a
definite classification of the tumor (Fig 2, C). On the
basis of histologic study, malignancy was diagnosed in
17 of 23 patients (74%) whereas benign lesions were
found in 6 patients (26%). Transesophageal biopsy
failed to establish a correct diagnosis in 3 of 26 patients
(12%). Recurrent esophageal cancer was observed in 1
patient although transesophageal biopsy had shown a
benign lymph node a few months before. In 2 cases fine
needle aspiration of a paraesophageal lymph node
yielded nondiagnostic material (ie, fibrotic and fatty tis-
Fig 1. A, Computed tomographic scan shows mediastinal lymph nodes (arrow) between esophagus (-) and aorta.
B, EUS accurately displays the needle (arrow) in a small para-aortic lymph node (arrowheads). AO, Aorta.
sue). The detailed results of EUS-guided biopsy are
shown in Table I.
EUS-guided biopsy improved the assessment of medi-
astinal lymph nodes (Table II) and had considerable
impact on the diagnosis and therapy of mediastinal
tumors. Biopsy confirmed the suspected diagnosis and
provided a precise histologic classification of the tumor
in 15 of 23 patients (65%). In 8 patients (35%) histologic
study altered the diagnosis suggested by the conventional
diagnostic evaluation (Table III). In 2 patients with sus-
pected recurrent esophageal cancer and non-Hodgkin’s
lymphoma, histologic examination revealed an inflam-
matory lymph node and sarcoidosis, respectively. The
first patient remains without evidence of recurrence after
a follow-up of 7 months, whereas sarcoidosis was con-
firmed by mediastinoscopy. In 2 further patients with
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“mediastinal non-Hodgkin’s lymphoma,” fine needle
aspiration disclosed cancer of an unknown primary (ade-
nocarcinoma) and small cell carcinoma of the lung.
Although imaging suggested cancer of the lung, recur-
rent gastric cancer was diagnosed in another patient 10
years after resection of the primary tumor. 
Mediastinal metastases of extrathoracic primary
tumors were excluded in 2 patients by EUS-guided
biopsy. Histologic examination revealed a mediastinal
goiter in a patient with a malignant melanoma of the
neck, a diagnosis that was subsequently also estab-
lished by scintigraphy. A secondary tumor, a small cell
carcinoma of the lung, was found in a patient who had
undergone nephrectomy for a renal carcinoma. 
The overall sensitivity and specificity of EUS-guided
biopsy for the diagnosis of malignancy were 89% and
Fig 2. A, Computed tomography demonstrates a pulmonary tumor (arrow) at the left hilum. –, Esophagus. B,
Transesophageal EUS-guided biopsy of the lesion with a fine needle (arrow). C, Core biopsy and immunohistochem-
istry with neuron-specific enolase–positive reddish cells demonstrate a small cell carcinoma.
C
83%, respectively. The positive predictive value was
100% and the negative predictive value was 75%. The
procedure was well tolerated by the patients and no
complications were observed related to transesopha-
geal biopsy. 
Discussion 
Because of the morbidity associated with diagnostic
thoracotomy, less-invasive procedures such as medi-
astinoscopy have been developed for tissue sampling of
mediastinal lesions.11-13 In recent years thoracoscopy
has been increasingly used for evaluation of mediastinal
lesions that are inaccessible to the mediastinoscope. The
morbidity rate of both procedures is low.14 However,
albeit rare, major complications such as hemorrhage
and recurrent nerve palsy have been observed.15,16
Furthermore, general anesthesia and hospitalization are
usually required for both techniques. 
The development of echoendoscopes with curved
array transducers offers a new modality for ultrasound-
guided biopsy of mediastinal lesions. However, as yet
only limited experience has been gained with this
method, mainly because of the lack of appropriate
biopsy needles.
In our experience, EUS with fine needle aspiration
proved to be a very safe and accurate method for tissue
sampling of mediastinal lesions. This technique pro-
vides access to regions that are not easily accessible by
cervical mediastinoscopy, that is, the posterior and infe-
rior mediastinum. However, visualization of lesions in
the anterior mediastinum is not possible because the air-
filled trachea prevents ultrasound transmission.
Real-time ultrasound visualization of the biopsy pro-
cedure enabled highly precise biopsy of small lesions
even in direct proximity to major vessels. Overall,
diagnostic biopsy specimens were obtained in 88% of
the cases (sensitivity, 89%; specificity, 83%). The high
accuracy of EUS-guided biopsy of mediastinal tumors
compares favorably with the results reported for gas-
trointestinal tumors. In a group of 45 patients with pan-
creatic tumors, Faigel and associates17 reached a rate of
91% diagnostic fine needle aspirations under EUS
guidance. Giovanini and coworkers18 achieved a sensi-
tivity of 77% and a specificity of 100% in the detection
of malignancy in 141 patients with various tumors.
Recently, encouraging results of EUS-guided biopsy of
mediastinal tumors have been presented in a prelimi-
nary report.19 A conclusive cytologic study was
obtained and confirmed in 12 of 13 lesions. In contrast
to this and some other studies,7,20 in our study the diag-
nosis was based on histologic analysis and not on cyto-
logic examination. The size and the quality of the tis-
sue samples were sufficient for routine staining and
histopathologic assessment of the biopsy specimen. It
is remarkable that immunohistochemistry could also be
performed in some cases to specify the diagnosis. 
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Table I. Histopathologic diagnosis of EUS-guided
biopsy in 29 patients with mediastinal and pulmonary
lesions
Location Histology No.
Mediastinal lymph nodes Recurrent gastric cancer 3
(n = 19) Lymphoma 1
Adenocarcinoma 1
Small cell carcinoma 1
Prostate cancer 1
Recurrent esophageal cancer 4
Benign lymph node 5
Non-representative 3
Mediastinal mass lesions Sarcoma 2
(n = 6) Melanoma 1
Thymoma 1
Small cell carcinoma 1
Goiter 1
Pulmonary tumors Small cell carcinoma 3
(n = 4) Adenocarcinoma 1
Table II. Correlation of endosonographic diagnosis and
histology of EUS-guided biopsy in 16 patients with
mediastinal lymph nodes
Histology
EUS diagnosis Malignant Benign
Malignant lymph node 10 3
Benign lymph node 1 2
Table III. EUS-guided biopsy changed the diagnosis
in 8 of 23 patients
Therapeutic 
Suspected diagnosis Histology consequence
Mediastinal primary
Lymphoma (n = 3) Adenocarcinoma (CUP) Chemotherapy
Small cell carcinoma Chemotherapy
Sarcoidosis* Medical therapy
Recurrent esophageal Benign lymph node† Follow-up
cancer
Lung cancer Recurrent gastric cancer Chemotherapy
Mediastinal secondary
Malignant melanoma Goiter‡ No therapy
Renal cell carcinoma Small cell carcinoma Chemotherapy
Sarcoma Complete necrosis Resection
CUP, Cancer of unknown primary.
*Confirmation by mediastinoscopy.
†Confirmation by 7-month follow-up.
‡Confirmation by scintigraphy.
Ultrasound-guided biopsy greatly increased the accu-
racy of EUS in the classification of mediastinal lymph
nodes (ie, malignant vs benign). Histologic study dis-
closed a false positive EUS diagnosis in 3 of 13 patients
with suspected malignant lymph nodes. On the other
hand, metastatic spread was found in 1 of 3 patients
although benign lymph nodes were suggested by EUS.
These data demonstrate that EUS-guided biopsy is
capable of improving the staging of mediastinal lymph
nodes, which can be of major importance for the thera-
peutic strategy in patients with thoracic tumors.
Recently, Silvestri and associates21 evaluated the util-
ity of this modality for staging of lung cancer in 27
patients. EUS-guided fine needle aspiration biopsy
enabled detection of lymph node metastases with a sen-
sitivity of 89%. It has also been reported that this tech-
nique is more accurate in the assessment of lymph node
involvement from lung cancer than computed tomogra-
phy (95% vs 43%).22 Surgery was abandoned in 59% of
the patients, because mediastinal lymph node metas-
tases were established by transesophageal biopsy.
Besides improved staging of known primary tumors,
EUS-guided biopsy can provide a histopathologic diag-
nosis of indeterminate mediastinal tumors that are not
accessible for other nonsurgical techniques, for example,
bronchoscopy. In this study biopsy confirmed the sus-
pected diagnosis in 19 of 27 patients, whereas an unex-
pected diagnosis was disclosed in 8 patients (30%).
Notably, biopsy did not confirm metastases in 2 patients
with suspicious mediastinal lymph nodes and a history
of cancer. In a patient with a melanoma, biopsy showed
an intrathoracic goiter, whereas a secondary tumor (lym-
phoma) was found in a patient with a hypernephroma.
These findings support the need for histologic confirma-
tion of the diagnosis even in apparently clear cases. 
We have not observed any complications related to
EUS-guided biopsy. However, needle tract seeding can
occur after transcutaneous needle biopsy of malignant
tumors. In a follow-up survey involving 95,000 fine
needle biopsies, metastases in the biopsy canal were
observed in only 6 cases (0.006%).23 Overall, the risk
of tumor cell dissemination by fine needle biopsy
seems to be low. Nonetheless, we would suggest that
EUS-guided biopsy be preferentially applied to patients
with nonresectable or metastatic disease.
In conclusion, EUS with ultrasound-guided biopsy is
a valuable method for the diagnostic evaluation of
mediastinal tumors and the staging of lymph nodes.
This minimally invasive technique allows precise tissue
sampling of lesions in the posterior mediastinum. In
selected cases, EUS-guided biopsy can obviate the
need for diagnostic surgical procedures, that is, medi-
astinoscopy and thoracoscopy. 
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Commentary
The article by Hünerbein and associates describes the
potential usefulness of endoscopic ultrasonography (EUS)
with needle biopsy for the evaluation of mediastinal structures
adjacent to the esophagus. Their experience mirrors my expe-
rience at the Medical University of South Carolina (MUSC).
Although EUS is not yet a common procedure in many cen-
ters in the United States, I anticipate that its utility will
increase as physicians recognize the clinical relevance and
very minimally invasive nature of the procedure. EUS with
biopsy does require gastroenterologists trained in the tech-
nique and close cooperation with the thoracic surgeons.
At MUSC, my colleagues and I have used EUS and fine
needle aspiration (FNA) to evaluate more than 140 patients
with a lung mass and mediastinal adenopathy. The radi-
ographically designated abnormal lymph nodes in both the
aortopulmonary window and the subcarinal region are now
preferentially evaluated by EUS/FNA. In the period from
June 1994 to September 1997, 82 patients with a lung mass
and mediastinal adenopathy underwent EUS/FNA. The sen-
sitivity for the diagnosis of malignancy was 88% and the
specificity was 100%. More than 30 patients with abnormal
mediastinal adenopathy without a dominant pulmonary mass
have also been evaluated by EUS/FNA. Similar to the find-
ings of Hünerbein and colleagues, a variety of disease
processes have been diagnosed, including sarcoidosis, histo-
plasmosis, lymphoma, and small cell lung cancer.
Our experience has been confined to aspiration cytology.
The development of a specialized needle that is capable of giv-
ing a core biopsy for histologic evaluation may be particularly
helpful in cases of lymphoma and granulomatous disease. Like
the authors, we have observed no complications from
EUS/FNA.
As a diagnostic and staging tool, EUS/FNA is meant to be
a complementary procedure to cervical mediastinoscopy and
thoracoscopy. In our hands, EUS/FNA is less invasive and
more cost effective when applied to the correct situation. In
my opinion, other reports will soon verify the results in the
present article as surgeons become familiar with the potential
usefulness of EUS-guided needle biopsy.
Carolyn E. Reed, MD
Charleston, SC
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